Forecasting influenza evolution on a heterogeneous immune landscape
Project Number1R01AI165821-01
Contact PI/Project LeaderBEDFORD, TREVOR BC Other PIs
Awardee OrganizationFRED HUTCHINSON CANCER RESEARCH CENTER
Description
Abstract Text
PROJECT SUMMARY
Influenza virus evolves rapidly to escape immunity elicited by prior infections and vaccinations. To combat this
evolution, the strains in the influenza vaccine are updated every season to keep pace with viral evolution.
However, it is currently difficult to accurately forecast which viral strain will dominate the coming season, and
vaccines are less effective when the wrong strain is chosen for the vaccine. Here we propose a combined
experimental / computational approach that will overcome some of the factors that currently make vaccine strain
selection so difficult. First, we will use a new deep mutational scanning approach to directly map the genotypes
of the viral surface proteins to their antigenic phenotype with respect to human antibody immunity. Second, we
will use this new experimental approach to reconstruct the heterogeneous human immune landscape over which
influenza virus evolves. Finally, we will build computational models that forecast how influenza evolves year-to-
year in response to human immunity. All of our data and forecasts will be integrated into easy-to-use interactive
visualizations. Overall, this work will improve the capacity to accurately identify which viral strains should be
selected for the seasonal influenza vaccine.
Public Health Relevance Statement
PROJECT NARRATIVE
We will combine new experimental and computational approaches to better forecast influenza evolution to inform
the selection of viral strains for the annual vaccine. Specifically, we will use high-throughput experiments to map
how different viral variants are recognized by human immunity, and then use these data to forecast which strains
will dominate the coming season.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
078200995
UEI
HMSNCM57QNR5
Project Start Date
15-February-2022
Project End Date
31-March-2022
Budget Start Date
15-February-2022
Budget End Date
31-March-2022
Project Funding Information for 2022
Total Funding
$35,200
Direct Costs
$20,000
Indirect Costs
$15,200
Year
Funding IC
FY Total Cost by IC
2022
National Institute of Allergy and Infectious Diseases
$35,200
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AI165821-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AI165821-01
Patents
No Patents information available for 1R01AI165821-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AI165821-01
Clinical Studies
No Clinical Studies information available for 1R01AI165821-01
News and More
Related News Releases
No news release information available for 1R01AI165821-01
History
No Historical information available for 1R01AI165821-01
Similar Projects
No Similar Projects information available for 1R01AI165821-01